# ANDA212953
> **ANDA212953** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2022-07-15
## Drug
- **FDA Application Number:** ANDA212953
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** MYLAN PHARMS INC
- **First approval:** 2022-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212953)
---
*AI Analytics · CC0 1.0*